Sign in
Taking peopleNo phase

Use of EBPT in Critically Ill Patients With AKI and/or Multiorgan Failure

Key facts

Who runs it
Careggi Hospital
Where
Italy15 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
1,000 people, planned
Started
16 Jul 2019
Planned end
30 Sept 2025
Type of study
Observational
Treatments tested
  • Commercial membrane for Extracorporeal Blood Purification Therapy (EBPT)
Record updated
12 February 2025

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • critically ill patients in the ICU
  • one of this EPB therapy:
  • CRRT/IHD/Hybrid therapies for support//replacement renal function
  • immunomodulation achieved by "high cut-off membranes", "endotoxins and/or cytokines adsorbent membranes" or by high-volume hemofiltration

Who cannot take part

  • patients treated only by Cytosorb® and/or Toraymyxin® therapies

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The use of extracorporeal blood purification therapies (EBPT) is becoming increasingly widespread worldwide in everyday clinical practice, particularly in the critical care setting. Nonetheless, most of the clinical trials aimed at exploring the effect of EBPT on patients' long-term outcomes have failed to demonstrate consistent results regarding 28 day- or hospital- mortality rates. The aim of this observational prospective registry is to evaluate if there is a cluster of critically ill patients that mostly benefits from extracorporeal blood purification therapies with different EBPTs.

The group in the trial

  • Critically ill patients

    In centres that obtained IRB approval for this prospective study, all critically ill patients undergoing EBPTs for support/replacement renal function or immunomodulation will be prospectively observed.

    Treatment: Commercial membrane for Extracorporeal Blood Purification Therapy (EBPT)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Use of EBPT in Critically Ill Patients With AKI and/or Multiorgan Failure: a Multicenter Prospective Observational Registry
Record updated
12 February 2025